Advertisement

Topics

Search Results for "Dcis Recurrence After Mastectomy"

12:15 EST 13th February 2016 | BioPortfolio

Matching Channels

Tumor recurrence

Oncotrace

For optimal treatment in cancerology, clinicians need specific, precise, sensitive methods to quantify treatment response, monitor residual disease and detect early recurrence in patients. Residual ...

WolffParkinsonWhite WPW syndrome

Wolff–Parkinson–White syndrome (WPW) is a syndrome of pre-excitation of ventricles of the heart due to an accessory pathway known as the bundle of Kent. This accessory pathway is an abno...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It...

Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...

Matching News

Higher local recurrence after skin-sparing than simple mastectomy for DCIS

Prof Bundred talks to ecancertv at SABCS 2015 about a retrospective study comparing local recurrence rates after simple mastectomy or skin-sparing mastectomy for ductal carcinoma in situ (DCIS). Tra...

No significant differences in recurrence rates among women with DCIS taking anastrozole or tamoxifen

(American Association for Cancer Research) Postmenopausal women with ductal carcinoma in situ (DCIS) had similar outcomes with disease recurrence whether they took tamoxifen or the aromatase inhibitor...

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Prof Cuzick presents, at a press conference at SABCS 2015 about the results from the phase III IBIS-II DCIS clinical trial. The data showed postmenopausal women with ductal carcinoma in situ had simi...

New Data on DCIS Recurrence Good News for Patients Electing Breast-Conserving Surgery

Our study shows a declining rate of recurrence over the decades, suggesting that for a woman treated today, the expected recurrence rate should be lower than that seen in the randomized trials.

Breast Cancer Research and Treatment Publishes Oncotype DX DCIS Score Study Conducted in Canada

Genomic Health has announced that Breast Cancer Research and Treatment published results from a second large clinical validation study of Oncotype DX in patients with stage 0 breast cancer, also known...

Treatment patterns for DCIS shift from 1991 to 2010

(HealthDay)—There were substantial shifts in treatment patterns for ductal carcinoma in situ (DCIS) from 1991 to 2010, with more women opting for lumpectomy and radiation therapy rather than single ...

DCIS Recurrence Rates Cut in Half

Five-year recurrence rates for women with ductal carcinoma in situ have been cut in half recently due to advances in mammography and more detailed pathology assessments.

Single Mastectomy Saves Money Compared With Double Mastectomy

An analysis of outcomes over 10 years suggests that single mastectomy is cheaper and improves quality of life when compared with contralateral prophylactic mastectomy. Medscape Medical News

Matching PubMed Articles

The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors.

The objective of this retrospective study was to determine the incidence of recurrence of breast cancer after mastectomy for ductal carcinoma in situ (DCIS) in our institution, and to evaluate the ass...

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

There are increasing rates of mastectomy and bi-lateral mastectomy in women diagnosed with ductal carcinoma in situ (DCIS). To help women avoid decisions that lead to unnecessary aggressive treatments...

Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey.

Introduction: Ductal carcinoma in situ (DCIS) is a premalignant lesion of the glandular component of the breast and a precursor lesion of invasive breast cancer. In recent decades the incidence of DCI...

Conservative mastectomies for breast cancer and risk-reducing surgery: the Memorial Sloan Kettering Cancer Center experience.

Demand for conservative mastectomies continues to increase as more patients choose to undergo breast reconstruction, often with simultaneous contralateral prophylactic mastectomy (CPM). In addition, t...

Radiotherapy of Ductal Carcinoma In Situ.

Ductal carcinoma in situ (DCIS) is a heterogeneous disease in both its biology and clinical course. In the past, recurrence rates after breast-conserving surgery have been as high as 30% after 10 year...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement